A report on
current global
access to new
childhood
vaccines
VIMS Report:
Global Vaccine Introduction
March, 2012
Developed from information in the VIMS Database
(www.jhsph.edu/ivac/vims.html)
Johns Hopkins Bloomberg School of Public Health
International Vaccine Access Center (IVAC)
Contact: [email protected]
International Vaccine
Access Center (IVAC)
Johns Hopkins Bloomberg
School of Public Health
Rangos Bldg, Suite 600
855 N. Wolfe Street
Baltimore, MD 21205
www.jhsph.edu/ivac
Updates Include:
Universal and regional vaccine introduction updates for 2012
Reformatted style of report for ease of utilization
TABLE OF CONTENTS
Vaccine Introduction Dashboard
Executive Summary
Methods
Updates on Global and GAVI Uptake for Hib, Pneumococcal Conjugate and Rotavirus Vaccines
•
•
Introduction trends over time
• A line graph that displays the rate of vaccine introduction since 2000 and projected to 2020 both globally and for GAVI eligible countries.
Current Global and GAVI Introduction Statuses
• A pie chart portraying current global and GAVI vaccine introduction statuses.
• World maps portraying vaccine introduction status globally and in GAVI countries.
•
•
•
Present Coverage
• A pie chart portraying the proportion of children who are likely to receive the vaccination based upon the coverage rates of countries that have introduced.
Present Access
• A pie chart portraying the proportion of children who live in a country that has introduced the vaccine into their national immunization program.
Vaccine introduction by income level
• A line graph comparing the historical and projected rate of PCV and Hib vaccine introduction in High and Low income countries.
Table 1. Introduction Status by Vaccine for All Countries
•
The status of Hib, Pneumococcal Conjugate and Rotavirus Vaccine for each country.
Acknowledgement and Notes
Appendix
•
The appendix includes a description of VIMS, support and funding for VIMS, how to sign up for VIMS and how to cite VIMS as
a source.
This report can be found at: http://www.jhsph.edu/ivac/index.html. The full report with forecast data and a PowerPoint presentation
with graphics can be found in the VIMS database. To gain access to VIMS, please email [email protected].
1
VACCINE INTRODUCTION DASHBOARD
Year of First Vaccine Introduction
Income Level
High Income
Middle Income
Low Income
GAVI Supported
Hib Vaccine
1989 (Iceland)
1994 (2 countries)
1997 (Gambia)
2001 (2 countries)
PCV
2000 (US)
2008 (5 countries)
2009 (Rwanda)
2009 (2 countries)
Rotavirus Vaccine
2006 (3 countries)
2006 (5 countries)
None
2008 (Bolivia)
Total number of countries that have introduced each vaccine
Vaccine
Hib
PCV
Rotavirus
2
Universal
177
74
32
Global Introduction
(194 Countries)
At Risk
10
Regional
1
3
2
GAVI Eligible
73 Countries
Total
65
16
6
178
87
34
EXECUTIVE SUMMARY
The following report displays data and figures on the introduction status of Hib vaccine, pneumococcal
conjugate vaccine (PCV) and rotavirus vaccine both globally and in 73 GAVI eligible countries. It uses
information stored in the Vaccine Information Management System (VIMS) online database maintained by
IVAC at the Johns Hopkins Bloomberg School of Public Health and supported by the GAVI Alliance. The
images and text below describe: how many countries have introduced each vaccine or plan to in the future;
global and GAVI rates of coverage and access; historical trends of the rate of introduction globally; and the
introduction status of every country individually. The report concludes with a more detailed description of
VIMS and its potential uses with an example of a VIMS country report.
3
METHODS
This report has been generated by the Vaccine Information Management System (VIMS) database developed and maintained at the Johns Hopkins Bloomberg School of Public Health for use by the International
Vaccine Access Center (IVAC) and its affiliated projects and partners. VIMS provides a centralized, webbased warehouse for key information related to IVAC’s work. Information was gathered from internationally
recognized sources, such as UNICEF, World Health Organization, vaccine manufacturers, ministries of
health and news media.
Current Global and GAVI Introduction Statuses for Hib, Pneumococcal Conjugate and Rotavirus Vaccines
•
Data on historical years of vaccine introduction are gathered from the WHO. Information on current introduction status are gathered from internationally recognized sources, such as UNICEF, WHO, vaccine manufacturers, ministries of health and news media.
Forecasted introduction dates are from AVI Strategic Demand Forecast v4.0 and WHO updates. For more information on sources,
see data inside VIMS or email [email protected].
Present Coverage
•
Coverage in each country was calculated with the following formula: Introduction Value*Surviving Infants*(DTP3 Coverage Rate). The country receives an Introduction Value of 1 if the vaccine has been universally or regionally introduced into the Routine Immunization Program.
The country receives an Introduction Value of 0 if the vaccine has NOT been introduced into the Routine Immunization Program.
Present Access
•
Access in each country was calculated with the following formula: Introduction Value*Surviving Infants. The country receives an
Introduction Value of 1 if the vaccine has been universally or regionally introduced into the Routine Immunization Program. The country
receives an Introduction Value of 0 if the vaccine has NOT been introduced into the Routine Immunization Program.
Note on Regional Introduction Coverage and Access Calculations
•
To calculate coverage or access in countries that have introduced regionally, the number of surviving infants in the region that
introduced the vaccine was estimated by multiplying the total number of surviving infants in the country by the proportion of the
total population that live in the regions that introduced the vaccine.
Vaccine introduction by income level
•
Countries were classified using 2011 World Bank income classifications. Year of introduction or forecasted introduction
was determined through WHO reports, news media and AVI Strategic Demand Forecast v4.0.
Table 1. Introduction Status by Vaccine for All Countries
•
This table uses WHO and GAVI Alliance information, as well as corroborated media reports, to list the status and date of
introduction of Hib, Pneumococcal Conjugate and Rotavirus Vaccine for each country.
Projected introduction dates for GAVI countries are taken from the most recent publicly available AVI Strategic Demand Forecast and
WHO information. For non-GAVI countries, the World Health Organization and a variety of other sources are used.
Information on a particular country’s GAVI application status or projected introduction dates may be sensitive and is not for public
circulation without prior consent from VIMS personnel. If data is used in a presentation, it should include a statement indicating this.
4
Global Hib Vaccine Introduction by Year
200
180
160
Number of Countries
140
120
100
80
60
40
20
0
52% of the world’s infants (66.6 million) are not likely to receive Hib
vaccine this year because either their country has not yet introduced
it, or they are not receiving routine immunizations (measured by
DTP3 coverage).
45% of the world’s infants (57.3 million) live in countries or
regions that have not yet introduced Hib vaccine into their National
Immunization Program.
Present Hib Coverage
(Global Surviving Infants)
Present Hib Access
(Global Surviving Infants)
No
Coverage
52%
With
Coverage
48%
Present Hib Coverage is calculated as the number of surviving
infants globally covered by DTP3 vaccine in countries or
regions of countries that have introduced Hib vaccine.
5
No
Access
45%
With
Access
55%
Present Hib Access is calculated as the number of surviving
infants globally that live in countries or regions of countries
that have introduced Hib vaccine.
Global Hib Vaccine Introduction Status
No Decision
178 countries (92%) have introduced a
Hib-containing vaccine into their National
Immunization Program. This includes
universal, regional and at risk prorams. 12
countries (6%) have announced plans to
introduce a Hib-containing vaccine into their
NIP. 1 country (1%) is known to have coverage
at greater than 50% through the private
market. 3 countries (2%) have yet to make a
decision regarding introduction.
A map of countries that have introduced
Hib vaccine below.
Already Introduced
(Universal)
As of February 2012
177 Countries
Already Introduced
(Regional)
As of February 2012
1 Country
6
Widespread
Private Market
Planning
Introduction
Introduced into
National
Program
GAVI Hib Vaccine Introduction by Year
80
70
Number of Countries
60
50
40
30
20
10
0
57% of infants in GAVI countries (42.9 million) are not likely to
receive Hib vaccine this year because either their country has not
yet introduced it, or they are not receiving routine immunizations
(measured by DTP3 coverage).
48% of infants in GAVI countries (36.2 million) live in countries or
regions that have not yet introduced Hib vaccine into their National
Immunization Program.
Present Hib Coverage
(GAVI Surviving Infants)
Present Hib Access
(GAVI Surviving Infants)
No
Coverage
57%
With
Coverage
43%
Present Hib Coverage is calculated as the number of surviving
infants by GAVI country covered by DTP3 vaccine in countries
or regions of countries that have introduced Hib vaccine.
7
No Access
48%
With
Access
52%
Present Hib Access is calculated as the number of surviving
infants by GAVI country that live in countries or regions of
countries that have introduced Hib vaccine.
GAVI Hib Vaccine Introduction Status
No Decision
GAVI
Approved/
Approved
with
Clarification
65 countries (89%) have introduced a
Hib-containing vaccine into their National
Immunization Program. This includes
universal, regional and at risk programs.
5 countries (7%) have approved, with or
without clarification, GAVI support to
introduce. 1 country (1%) has conditional
GAVI approval to introduce. 1 country (1%)
has announced plans to apply for GAVI
support. 1 country (1%) has yet to make a
decision regarding introduction.
A map of GAVI countries that have
introduced Hib vaccine below.
GAVI
Conditional
Approval
GAVI Plan to
Apply
Introduced
into National
Program
Already Introduced
(Universal)
64 Countries
Already Introduced
(Regional)
1 Country
Countries Eligible for GAVI
Support*
*Angola, Armenia, Azerbaijan, Bhutan, Bolivia, Congo, Cuba, Georgia, Guyana, Honduras, Indonesia, Kiribati, Moldova, Mongolia, Sri Lanka,
and Ukraine are graduating from GAVI in 2012 and are no longer eligible to apply for new vaccine support.
8
Global PCV Introduction by Year
160
140
Number of Countries
120
100
80
60
40
20
0
77% of the world’s infants (98.7 million) are not likely to receive
PCV this year because either their country has not yet introduced it,
or they are not receiving routine immunizations (measured by DTP3
coverage).
Present PCV Coverage
(Global Surviving Infants)
74% of the world’s infants (95.3 million) live in countries or regions
that have not yet introduced PCV into their National Immunization
Program.
Present PCV Access
(Global Surviving Infants)
With
Coverage
23%
No
Coverage
77%
Present PCV Coverage is calculated as the number of surviving
infants globally covered by DTP3 vaccine in countries or
regions of countries that have introduced PCV.
9
With
Access
26%
No
Access
74%
Present PCV Access is calculated as the number of surviving
infants globally that live in countries or regions of countries
that have introduced PCV.
Global PCV Introduction Status
Widespread
Private
Market
87 countries (45%) have introduced PCV
into their National Immunization Program.
This includes universal, regional and at
risk programs. 58 countries (30%) have
announced plans to introduce PCV into
their NIP. 2 countries (1%) are known to
have coverage at greater than 50% through
the private market. 47 countries (24%)
have yet to make a decision regarding
introduction.
A map of countries that have introduced
PCV below.
Universal or
Regional Program
(77 Countries)
At Risk Program
(10 Countries)
10
No Decision
Introduced
into National
Program
Planning
Introduction
GAVI PCV Introduction by Year
70
60
Number of Countries
50
40
30
20
10
0
88% of infants in GAVI countries (66.0 million) are not likely to
receive PCV this year because either their country has not yet
introduced it, or they are not receiving routine immunizations
(measured by DTP3 coverage).
85% of infants in GAVI countries (63.9 million) live in countries
or regions that have not yet introduced PCV into their National
Immunization Program.
Present PCV Coverage
(GAVI Surviving Infants)
Present PCV Access
(GAVI Surviving Infants)
With
Coverage
12%
No
Coverage
88%
Present PCV Coverage is calculated as the number of surviving
infants by GAVI country covered by DTP3 vaccine in countries
or regions of countries that have introduced PCV.
11
With
Access
15%
No Access
85%
Present PCV Access is calculated as the number of surviving
infants by GAVI country that live in countries or regions of
countries that have introduced PCV.
GAVI PCV Introduction Status
16 countries (22%) have introduced PCV
into their National Immunization Program.
This includes universal, regional and at
risk programs. 21 countries (29%) have
approved, with or without clarification,
GAVI support to introduce. 11 countries
(15%) have conditional GAVI approval
to introduce. 15 countries (21%) have
announced plans to introduce PCV into
their NIP. 10 countries (14%) have yet to
make a decision regarding PCV.
A map of GAVI countries that have
introduced PCV below.
Introduced
into National
Program
GAVI
Approved/
Approved with
Clarification
No Decision
GAVI
Conditional
Approval
Planning
Introduction
Already Introduced
16 Countries
Countries Eligible for
GAVI Support*
*Angola, Armenia, Azerbaijan, Bhutan, Bolivia, Congo, Cuba, Georgia, Guyana, Honduras, Indonesia, Kiribati, Moldova, Mongolia, Sri Lanka,
and Ukraine are graduating from GAVI in 2012 and are no longer eligible to apply for new vaccine support.
12
Global Rotavirus Vaccine Introduction by Year
120
100
Number of Countries
80
60
40
20
0
86% of the world’s infants (110.6 million) are not likely to receive
Rotavirus vaccine this year because either their country has not
yet introduced it, or they are not receiving routine immunizations
(measured by DTP3 coverage).
Present Rotavirus Coverage
(Global Surviving Infants)
84% of the world’s infants (108.5 million) live in countries or regions
that have not yet introduced Rotavirus vaccine into their National
Immunization Program.
Present Rotavirus Access
(Global Surviving Infants)
With
Coverage
14%
No
Coverage
86%
Present Rotavirus Coverage is calculated as the number of
surviving infants globally covered by DTP3 vaccine in countries
or regions of countries that have introduced Rotavirus vaccine.
13
With
Access
16%
No Access
84%
Present Rotavirus Access is calculated as the number of
surviving infants globally that live in countries or regions of
countries that have introduced Rotavirus vaccine.
Global Rotavirus Vaccine Introduction Status
Widespread
Private
Market
34 countries (18%) have introduced
Rotavirus vaccine into their National
Immunization Program. This includes
universal, regional and at risk programs.
57 countries (29%) have announced plans
to introduce Rotavirus vaccine into their
NIP. 2 countries (1%) are known to have
coverage at greater than 50% through
the private market. 101 countries (52%)
have yet to make a decision regarding
introduction.
A map of countries that have introduced
Rotavirus vaccine below.
Introduced Universal
Program (32 Countries)
Regional Program
(2 Countries)
14
Planning
Introduction
No Decision
Introduced
into
National
Program
GAVI Rotavirus Vaccine Introduction by Year
70
60
Number of Countries
50
40
30
20
10
0
98% of infants in GAVI countries (73.2 million) are not likely to
receive Rotavirus vaccine this year because either their country has
not yet introduced it, or they are not receiving routine immunizations
(measured by DTP3 coverage).
Present Rotavirus Coverage
(GAVI Surviving Infants)
98% of infants in GAVI countries (73.0 million) live in countries
or regions that have not yet introduced Rotavirus vaccine into their
National Immunization Program.
Present Rotavirus Access
(GAVI Surviving Infants)
With
Access
2%
With
Coverage
2%
No
Coverage
98%
Present Rotavirus Coverage is calculated as the number of
surviving infants by GAVI country covered by DTP3 vaccine
in countries or regions of countries that have introduced
Rotavirus vaccine.
15
No Access
98%
Present Rotavirus Access is calculated as the number of
surviving infants by GAVI country that live in countries or
regions of countries that have introduced Rotavirus vaccine.
GAVI Rotavirus Vaccine Introduction Status
6 countries (8%) have introduced Rotavirus
vaccine into their National Immunization
Program. This includes universal, regional
and at risk programs. 16 countries (22%)
are approved, with or without clarification,
for GAVI support to introduce. 7 countries
(10%) have conditional GAVI approval
to introduce. 21 countries (29%) have
announced plans to introduce Rotavirus
vaccine into their NIP. 23 countries (31%)
have yet to make a decision regarding
introduction.
A map of GAVI countries that have
introduced Rotavirus vaccine below.
Introduced
into
National
Program
GAVI
Approved/
Approved
with
Clarification
GAVI
Conditional
Approval
No Decision
Planning
Introduction
Already Introduced
(Universal Program)
5 Countries
Already Introduced
(Regional Program)
1 Country
Countries Eligible for
GAVI Support*
*Angola, Armenia, Azerbaijan, Bhutan, Bolivia, Congo, Cuba, Georgia, Guyana, Honduras, Indonesia, Kiribati, Moldova, Mongolia, Sri Lanka,
and Ukraine are graduating from GAVI in 2012 and are no longer eligible to apply for new vaccine support.
16
Vaccine Introduction by Income Group
100%
90%
Percentage of countries that have
universally introduced vaccine
80%
7 years
70%
60%
Hib HI C
50%
Hib LI C
PCV HI C
40%
PCV LI C
30%
20%
10%
0%
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Year since first introduction
Note: Limited projections are available for PCV introduction in High Income Countries
A line graph showing the proportion of high and low income countries that have introduced or are projected to
introduce PCV and Hib vaccine over time. Year of first introduction is 1989 for Hib vaccine and 2000 for PCV.
It took 20 years for Hib vaccine to reach 70% of low income countries. PCV is projected to reach 70% of low
income countries seven years faster, protecting millions of children sooner from deadly pneumococcal disease.
17
21
22
Table 1. Introduction Status by Vaccine for All Countries
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
AFGHANISTAN
Introduced into NIP:
Universal
1/11/2009 (Exact)
GAVI conditional
approval to introduce
ALBANIA
Introduced into NIP:
Universal
2/1/2009 (Day
Unknown)
Introduced into NIP:
Universal
ALGERIA
Introduced into NIP:
Universal
10/1/2008 (Day
Unknown)
No Decision
ANDORRA
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
ANGOLA
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
GAVI approved/
approved with
clarification
GAVI approved/
approved with
clarification
ANTIGUAANDBARBUDA Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
No Decision
No Decision
ARGENTINA
Introduced into NIP:
Universal
1/1/1997 (Month
Unknown)
Introduced into NIP:
Risk
ARMENIA
Introduced into NIP:
Universal
8/12/2009 (Exact)
GAVI approved/
approved with
clarification
AUSTRALIA
Introduced into NIP:
Universal
1/1/1993 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2005 (Day
Unknown)
Introduced into NIP:
Universal
1/1/2007 (Month
Unknown)
AUSTRIA
Introduced into NIP:
Universal
1/1/1994 (Month
Unknown)
Introduced into NIP:
Risk
9/1/2004 (Day
Unknown)
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
AZERBAIJAN
Introduced into NIP:
Universal
8/1/2011 (Day
Unknown)
GAVI approved/
approved with
clarification
BAHAMAS
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2009 (Month
Unknown)
No Decision
BAHRAIN
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
6/1/2008 (Day
Unknown)
Introduced into NIP:
Universal
BANGLADESH
Introduced into NIP:
Universal
7/1/2009 (Exact)
GAVI conditional
approval to introduce
18
Date of Introduction
Introduction Status
Date of Introduction
GAVI plan to apply
3/12/2011 (Exact)
Non-GAVI Planning
Introduction
No Decision
1/1/2007 (Month
Unknown)
1/1/2009 (Month
Unknown)
No Decision
No Decision
GAVI approved/
approved with
clarification
No Decision
GAVI plan to apply
1/1/2008 (Month
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
BARBADOS
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2009 (Month
Unknown)
No Decision
BELARUS
Introduced into NIP:
Regional
BELGIUM
Introduced into NIP:
Universal
1/1/1993 (Month
Unknown)
Introduced into NIP:
Universal
BELIZE
Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
No Decision
BENIN
Introduced into NIP:
Universal
1/1/2005 (Month
Unknown)
Introduced into NIP:
Universal
BHUTAN
Introduced into NIP:
Universal
6/1/2011 (Day
Unknown)
Non-GAVI Planning
Introduction
Non-GAVI Planning
Introduction
BOLIVIA
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
GAVI approved/
approved with
clarification
Introduced into NIP:
Universal
BOSNIA AND
HERZEGOVINA
Introduced into NIP:
Universal
11/1/2010 (Day
Unknown)
No Decision
No Decision
BOTSWANA
Introduced into NIP:
Universal
11/15/2010 (Day
Unknown)
Non-GAVI Planning
Introduction
Non-GAVI Planning
Introduction
BRAZIL
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
BRUNEI DARUSSALAM
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
Non-GAVI Planning
Introduction
BULGARIA
Introduced into NIP:
Universal
6/1/2010 (Day
Unknown)
Introduced into NIP:
Universal
BURKINA FASO
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
GAVI plan to apply
BURUNDI
Introduced into NIP:
Universal
1/1/2004 (Month
Unknown)
Introduced into NIP:
Universal
CAMBODIA
Introduced into NIP:
Universal
1/1/2010 (Month
Unknown)
GAVI plan to apply
19
No Decision
Date of Introduction
No Decision
1/1/2007 (Day
Unknown)
Introduced into NIP:
Universal
1/1/2007 (Day
Unknown)
No Decision
7/26/2011 (Exact)
11/1/2010 (Day
Unknown)
No Decision
Introduced into NIP:
Universal
No Decision
6/1/2010 (Month
Unknown)
No Decision
No Decision
9/20/2011 (Exact)
GAVI approved/
approved with
clarification
No Decision
1/1/2008 (Month
Unknown)
7/1/2006 (Day
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
CAMEROON
Introduced into NIP:
Universal
2/1/2009 (Exact)
Introduced into NIP:
Universal
7/1/2011 (Exact)
GAVI approved/
approved with
clarification
CANADA
Introduced into NIP:
Universal
1/1/1992 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
Introduced into NIP:
Regional
CAPE VERDE
Introduced into NIP:
Universal
1/1/2010 (Month
Unknown)
No Decision
CENTRAL AFRICAN
REPUBLIC
Introduced into NIP:
Universal
9/1/2008 (Exact)
Introduced into NIP:
Universal
CHAD
Introduced into NIP:
Universal
7/1/2008 (Exact)
No Decision
CHILE
Introduced into NIP:
Universal
1/1/1996 (Month
Unknown)
Introduced into NIP:
Universal
CHINA
Widespread coverage
through private market
COLOMBIA
Introduced into NIP:
Universal
COMOROS
12/1/2010 (Exact)
No Decision
6/30/2011 (Exact)
GAVI conditional
approval to introduce
No Decision
11/1/2010 (Day
Unknown)
No Decision
No Decision
No Decision
1/1/1998 (Month
Unknown)
Introduced into NIP:
Regional
Introduced into NIP:
Universal
Introduced into NIP:
Universal
8/1/2009 (Exact)
No Decision
No Decision
CONGO
Introduced into NIP:
Universal
1/13/2009 (Exact)
GAVI approved/
approved with
clarification
GAVI approved/
approved with
clarification
COOK ISLANDS
Introduced into NIP:
Universal
6/1/2009 (Day
Unknown)
No Decision
No Decision
COSTA RICA
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
CÔTE D’IVOIRE
Introduced into NIP:
Universal
3/1/2009 (Day
Unknown)
GAVI plan to apply
CROATIA
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
Introduced into NIP:
Risk
CUBA
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
No Decision
20
Date of Introduction
1/16/2009 (Exact)
Introduced into NIP:
Universal
GAVI plan to apply
11/1/2006 (Day
Unknown)
No Decision
No Decision
12/1/2010 (Exact)
5/1/2010 (Month
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
CYPRUS
Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
Introduced into NIP:
Universal
12/1/2005 (Day
Unknown)
Widespread coverage
through private market
CZECH REPUBLIC
Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2010 (Month
Unknown)
No Decision
KOREA, DEMOCRATIC
PEOPLE’S REPUBLIC OF
GAVI approved/
approved with
clarification
No Decision
No Decision
CONGO, THE
Introduced into NIP:
DEMOCRATIC REPUBLIC Universal
OF THE
1/1/2009 (Day
Unknown)
Introduced into NIP:
Universal
3/21/2011 (Day
Unknown)
No Decision
DENMARK
Introduced into NIP:
Universal
1/1/1993 (Month
Unknown)
Introduced into NIP:
Universal
10/1/2007 (Day
Unknown)
No Decision
DJIBOUTI
Introduced into NIP:
Universal
8/1/2007 (Day
Unknown)
GAVI approved/
approved with
clarification
DOMINICA
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
Introduced into NIP:
Risk
1/1/2010 (Month
Unknown)
No Decision
DOMINICAN REPUBLIC
Introduced into NIP:
Universal
1/1/2003 (Month
Unknown)
Introduced into NIP:
Risk
9/1/2009 (Day
Unknown)
No Decision
ECUADOR
Introduced into NIP:
Universal
1/1/2003 (Month
Unknown)
Introduced into NIP:
Universal
8/1/2010 (Day
Unknown)
Introduced into NIP:
Universal
EGYPT
Non-GAVI Planning
Introduction
EL SALVADOR
Introduced into NIP:
Universal
EQUATORIAL GUINEA
Non-GAVI Planning
Introduction
ERITREA
Introduced into NIP:
Universal
ESTONIA
Introduced into NIP:
Universal
21
GAVI approved/
approved with
clarification
No Decision
1/1/2002 (Month
Unknown)
Introduced into NIP:
Universal
Date of Introduction
1/1/2007 (Month
Unknown)
No Decision
11/1/2010 (Month
Unknown)
Introduced into NIP:
Universal
Non-GAVI Planning
Introduction
Non-GAVI Planning
Introduction
6/1/2008 (Day
Unknown)
GAVI plan to apply
GAVI plan to apply
1/1/2006 (Month
Unknown)
No Decision
No Decision
4/1/2006 (Day
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
ETHIOPIA
Introduced into NIP:
Universal
5/1/2007 (Day
Unknown)
Introduced into NIP:
Universal
10/15/2011 (Exact)
GAVI approved/
approved with
clarification
FIJI
Introduced into NIP:
Universal
1/1/1997 (Month
Unknown)
Introduced into NIP:
Universal
5/9/2011 (Exact)
Introduced into NIP:
Universal
5/9/2011 (Exact)
FINLAND
Introduced into NIP:
Universal
1/1/1990 (Month
Unknown)
Introduced into NIP:
Universal
9/1/2010 (Day
Unknown)
Introduced into NIP:
Universal
9/1/2009 (Day
Unknown)
FRANCE
Introduced into NIP:
Universal
1/1/1992 (Month
Unknown)
Introduced into NIP:
Universal
5/1/2006 (Day
Unknown)
No Decision
GABON
Introduced into NIP:
Universal
4/2/2010 (Exact)
Non-GAVI Planning
Introduction
GAMBIA
Introduced into NIP:
Universal
1/1/1997 (Month
Unknown)
Introduced into NIP:
Universal
GEORGIA
Introduced into NIP:
Universal
6/1/2010 (Month
Unknown)
GAVI approved/
approved with
clarification
GERMANY
Introduced into NIP:
Universal
1/1/1990 (Month
Unknown)
Introduced into NIP:
Universal
GHANA
Introduced into NIP:
Universal
1/1/2003 (Month
Unknown)
GAVI approved/
approved with
clarification
GREECE
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
Introduced into NIP:
Universal
GRENADA
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
No Decision
No Decision
GUATEMALA
Introduced into NIP:
Universal
No Decision
Introduced into NIP:
Universal
GUINEA
Introduced into NIP:
Universal
GAVI plan to apply
No Decision
GUINEA-BISSAU
Introduced into NIP:
Universal
GAVI conditional
approval to introduce
GAVI conditional
approval to introduce
GUYANA
Introduced into NIP:
Universal
Introduced into NIP:
Universal
Introduced into NIP:
Universal
22
Date of Introduction
No Decision
8/19/2009 (Exact)
No Decision
GAVI approved/
approved with
clarification
7/1/2006 (Day
Unknown)
Widespread coverage
through private market
GAVI approved/
approved with
clarification
1/1/2006 (Day
Unknown)
No Decision
1/1/2010 (Month
Unknown)
4/1/2010 (Day
Unknown)
HIB
PNEUMO
Country
Introduction Status
HAITI
GAVI approved/
approved with
clarification
HONDURAS
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
4/1/2011 (Exact)
Introduced into NIP:
Universal
HUNGARY
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
4/1/2009 (Day
Unknown)
No Decision
ICELAND
Introduced into NIP:
Universal
5/1/1989 (Day
Unknown)
Introduced into NIP:
Universal
1/1/2011 (Month
Unknown)
No Decision
INDIA
Introduced into NIP:
Regional
Non-GAVI Planning
Introduction
Non-GAVI Planning
Introduction
INDONESIA
GAVI conditional
approval to introduce
Non-GAVI Planning
Introduction
Non-GAVI Planning
Introduction
IRAN, ISLAMIC
REPUBLIC OF
Introduced into NIP:
Universal
9/1/2011 (Day
Unknown)
Introduced into NIP:
Universal
IRAQ
Introduced into NIP:
Universal
6/1/2011 (Day
Unknown)
Non-GAVI Planning
Introduction
IRELAND
Introduced into NIP:
Universal
1/1/1992 (Month
Unknown)
Introduced into NIP:
Universal
9/1/2008 (Day
Unknown)
No Decision
ISRAEL
Introduced into NIP:
Universal
1/1/1994 (Month
Unknown)
Introduced into NIP:
Universal
7/1/2009 (Day
Unknown)
Non-GAVI Planning
Introduction
ITALY
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
5/1/2005 (Day
Unknown)
No Decision
JAMAICA
Introduced into NIP:
Universal
1/1/2003 (Month
Unknown)
Introduced into NIP:
Universal
JAPAN
Introduced into NIP:
Universal
11/1/2010 (Day
Unknown)
Introduced into NIP:
Universal
11/1/2010 (Day
Unknown)
Non-GAVI Planning
Introduction
JORDAN
Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
Introduced into NIP:
Regional
1/1/2009 (Month
Unknown)
Non-GAVI Planning
Introduction
KAZAKHSTAN
Introduced into NIP:
Universal
7/1/2008 (Day
Unknown)
Introduced into NIP:
Universal
12/1/2010 (Day
Unknown)
No Decision
KENYA
Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
Introduced into NIP:
Universal
2/14/2011 (Exact)
GAVI conditional
approval to introduce
23
Date of Introduction
Introduction Status
ROTA
Date of Introduction
GAVI conditional
approval to introduce
Introduction Status
Date of Introduction
GAVI conditional
approval to introduce
9/1/2010 (Month
Unknown)
1/1/2009 (Month
Unknown)
Non-GAVI Planning
Introduction
Introduced into NIP:
Universal
No Decision
6/1/2011 (Day
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
KIRIBATI
Introduced into NIP:
Universal
9/1/2008 (Day
Unknown)
GAVI approved/
approved with
clarification
KUWAIT
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
KYRGYZSTAN
Introduced into NIP:
Universal
4/1/2009 (Exact)
GAVI plan to apply
GAVI plan to apply
LAO PEOPLE’S
Introduced into NIP:
DEMOCRATIC REPUBLIC Universal
9/8/2009 (Day
Unknown)
GAVI conditional
approval to introduce
No Decision
LATVIA
Introduced into NIP:
Universal
1/1/1994 (Month
Unknown)
Introduced into NIP:
Universal
LEBANON
Introduced into NIP:
Universal
1/1/2003 (Month
Unknown)
Introduced into NIP:
Risk
No Decision
LESOTHO
Introduced into NIP:
Universal
12/12/2008 (Exact)
GAVI conditional
approval to introduce
GAVI plan to apply
LIBERIA
Introduced into NIP:
Universal
1/1/2008 (Day
Unknown)
GAVI conditional
approval to introduce
No Decision
LIBYAN ARAB
JAMAHIRIYA
Introduced into NIP:
Universal
1/1/2007 (Month
Unknown)
Non-GAVI Planning
Introduction
Non-GAVI Planning
Introduction
LITHUANIA
Introduced into NIP:
Universal
1/1/2004 (Month
Unknown)
Non-GAVI Planning
Introduction
No Decision
LUXEMBOURG
Introduced into NIP:
Universal
1/1/2004 (Month
Unknown)
Introduced into NIP:
Universal
MADAGASCAR
Introduced into NIP:
Universal
7/1/2008 (Day
Unknown)
GAVI approved/
approved with
clarification
MALAWI
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
Introduced into NIP:
Universal
MALAYSIA
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
No Decision
No Decision
MALDIVES
Non-GAVI Planning
Introduction
No Decision
No Decision
24
Date of Introduction
Introduction Status
Date of Introduction
GAVI plan to apply
8/1/2006 (Day
Unknown)
1/1/2010 (Month
Unknown)
1/1/2005 (Day
Unknown)
Non-GAVI Planning
Introduction
No Decision
Introduced into NIP:
Universal
GAVI approved/
approved with
clarification
11/12/2011 (Exact)
GAVI approved/
approved with
clarification
1/1/2006 (Month
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
MALI
Introduced into NIP:
Universal
1/1/2008 (Month
Unknown)
Introduced into NIP:
Universal
3/15/2011 (Exact)
GAVI plan to apply
MALTA
Introduced into NIP:
Universal
1/1/1996 (Month
Unknown)
Introduced into NIP:
Risk
MARSHALL ISLANDS
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
MAURITANIA
Introduced into NIP:
Universal
3/1/2009 (Exact)
GAVI conditional
approval to introduce
No Decision
MAURITIUS
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
Non-GAVI Planning
Introduction
No Decision
MEXICO
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
3/1/2008 (Day
Unknown)
Introduced into NIP:
Universal
5/1/2007 (Day
Unknown)
MICRONESIA,
FEDERATED STATES OF
Introduced into NIP:
Universal
1/1/1996 (Month
Unknown)
Introduced into NIP:
Universal
3/1/2008 (Month
Unknown)
Introduced into NIP:
Universal
4/1/2008 (Day
Unknown)
MONACO
Introduced into NIP:
Universal
1/1/2004 (Month
Unknown)
No Decision
No Decision
MONGOLIA
Introduced into NIP:
Universal
1/1/2008 (Month
Unknown)
Non-GAVI Planning
Introduction
No Decision
MONTENEGRO
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
No Decision
No Decision
MOROCCO
Introduced into NIP:
Universal
1/1/2007 (Month
Unknown)
Introduced into NIP:
Universal
MOZAMBIQUE
Introduced into NIP:
Universal
10/1/2009 (Day
Unknown)
GAVI approved/
approved with
clarification
GAVI plan to apply
MYANMAR
GAVI plan to apply
No Decision
No Decision
NAMIBIA
Introduced into NIP:
Universal
9/9/2009 (Exact)
Non-GAVI Planning
Introduction
No Decision
NAURU
Introduced into NIP:
Universal
1/1/2009 (Month
Unknown)
No Decision
No Decision
NEPAL
Introduced into NIP:
Universal
12/1/2009 (Day
Unknown)
GAVI plan to apply
No Decision
25
Date of Introduction
No Decision
1/1/2009 (Month
Unknown)
10/20/2010 (Exact)
Introduced into NIP:
Universal
Introduced into NIP:
Universal
1/1/2009 (Month
Unknown)
10/20/2010 (Exact)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
NETHERLANDS
Introduced into NIP:
Universal
1/1/1993 (Month
Unknown)
Introduced into NIP:
Universal
6/1/2006 (Day
Unknown)
No Decision
NEW ZEALAND
Introduced into NIP:
Universal
1/1/1994 (Month
Unknown)
Introduced into NIP:
Universal
6/1/2008 (Day
Unknown)
No Decision
NICARAGUA
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
12/12/2010 (Exact)
Introduced into NIP:
Universal
NIGER
Introduced into NIP:
Universal
9/22/2008 (Exact)
GAVI approved/
approved with
clarification
GAVI approved/
approved with
clarification
NIGERIA
GAVI approved/
approved with
clarification
GAVI conditional
approval to introduce
Non-GAVI Planning
Introduction
NIUE
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2009 (Month
Unknown)
No Decision
NORWAY
Introduced into NIP:
Universal
1/1/1992 (Month
Unknown)
Introduced into NIP:
Universal
7/1/2006 (Day
Unknown)
No Decision
OMAN
Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2008 (Month
Unknown)
Non-GAVI Planning
Introduction
PAKISTAN
Introduced into NIP:
Universal
2/1/2009 (Day
Unknown)
GAVI approved/
approved with
clarification
PALAU
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Universal
3/1/2008 (Day
Unknown)
Introduced into NIP:
Universal
12/1/2008 (Month
Unknown)
PANAMA
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2011 (Month
Unknown)
Introduced into NIP:
Universal
2/1/2006 (Day
Unknown)
PAPUA NEW GUINEA
Introduced into NIP:
Universal
4/1/2008 (Day
Unknown)
GAVI conditional
approval to introduce
No Decision
PARAGUAY
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
No Decision
Introduced into NIP:
Universal
12/1/2009 (Month
Unknown)
PERU
Introduced into NIP:
Universal
1/1/2005 (Month
Unknown)
Introduced into NIP:
Universal
Introduced into NIP:
Universal
1/1/2009 (Month
Unknown)
PHILIPPINES
Introduced into NIP:
Universal
26
Non-GAVI Planning
Introduction
Date of Introduction
1/1/2006 (Month
Unknown)
GAVI plan to apply
1/1/2009 (Month
Unknown)
Introduced into NIP:
Universal
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
Date of Introduction
Introduction Status
POLAND
Introduced into NIP:
Universal
4/1/2007 (Day
Unknown)
No Decision
PORTUGAL
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
Widespread coverage
through private market
1/1/2001 (Month
Unknown)
No Decision
QATAR
Introduced into NIP:
Universal
1/1/1996 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2005 (Month
Unknown)
Introduced into NIP:
Universal
KOREA, REPUBLIC OF
No Decision
Widespread coverage
through private market
1/1/2004 (Month
Unknown)
No Decision
No Decision
MOLDOVA, REPUBLIC OF Introduced into NIP:
Universal
1/1/2009 (Day
Unknown)
GAVI approved/
approved with
clarification
GAVI approved/
approved with
clarification
ROMANIA
Introduced into NIP:
Universal
3/1/2010 (Day
Unknown)
No Decision
No Decision
RUSSIAN FEDERATION
Non-GAVI Planning
Introduction
No Decision
No Decision
RWANDA
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
Introduced into NIP:
Universal
SAINT KITTS AND NEVIS Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
No Decision
No Decision
SAINT LUCIA
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
No Decision
No Decision
SAINT VINCENT AND THE Introduced into NIP:
GRENADINES
Universal
1/1/2003 (Month
Unknown)
No Decision
No Decision
SAMOA
Introduced into NIP:
Universal
1/1/2007 (Month
Unknown)
No Decision
No Decision
SAN MARIO
Introduced into NIP:
Universal
1/1/1996 (Month
Unknown)
Introduced into NIP:
Universal
SAO TOME AND
PRINCIPE
Introduced into NIP:
Universal
10/1/2009 (Month
Unknown)
GAVI approved/
approved with
clarification
SAUDIA ARABIA
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
Introduced into NIP:
Universal
27
Date of Introduction
7/13/2009 (Day
Unknown)
1/1/2007 (Month
Unknown)
GAVI approved/
approved with
clarification
No Decision
GAVI plan to apply
3/1/2009 (Day
Unknown)
Non-GAVI Planning
Introduction
6/1/2008 (Day
Unknown)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
SENEGAL
Introduced into NIP:
Universal
1/1/2005 (Month
Unknown)
GAVI approved/
approved with
clarification
GAVI plan to apply
SERBIA
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
No Decision
No Decision
SEYCHELLES
Introduced into NIP:
Universal
11/1/2010 (Exact)
No Decision
No Decision
SIERRA LEONE
Introduced into NIP:
Universal
1/1/2007 (Day
Unknown)
Introduced into NIP:
Universal
1/28/2011 (Exact)
GAVI conditional
approval to introduce
SINGAPORE
Non-GAVI Planning
Introduction
Introduced into NIP:
Universal
11/1/2009 (Exact)
No Decision
SLOVAKIA
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
Introduced into NIP:
Universal
4/1/2008 (Day
Unknown)
No Decision
SLOVENIA
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
Introduced into NIP:
Risk
1/1/2005 (Month
Unknown)
No Decision
SOLOMON ISLANDS
Introduced into NIP:
Universal
8/1/2008 (Exact)
GAVI plan to apply
No Decision
SOMALIA
GAVI approved/
approved with
clarification
No Decision
No Decision
SOUTH AFRICA
Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
4/1/2009 (Exact)
Introduced into NIP:
Universal
SPAIN
Introduced into NIP:
Universal
1/1/1998 (Month
Unknown)
Introduced into NIP:
Risk
6/1/2001 (Day
Unknown)
No Decision
SRI LANKA
Introduced into NIP:
Universal
2/1/2010 (Exact)
No Decision
Non-GAVI Planning
Introduction
SUDAN
Introduced into NIP:
Regional
1/2/2008 (Exact)
GAVI approved/
approved with
clarification
Introduced into NIP:
Regional
SUDAN, REPUBLIC OF
SOUTH
No Decision
No Decision
No Decision
SURINAME
Introduced into NIP:
Universal
No Decision
No Decision
28
1/1/2005 (Month
Unknown)
Date of Introduction
Introduction Status
Date of Introduction
8/1/2009 (Exact)
7/18/2011 (Exact)
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
SWAZILAND
Introduced into NIP:
Universal
6/4/2009 (Exact)
Non-GAVI Planning
Introduction
SWEDEN
Introduced into NIP:
Universal
1/1/1992 (Month
Unknown)
Introduced into NIP:
Universal
1/1/2009 (Day
Unknown)
No Decision
SWITZERLAND
Introduced into NIP:
Universal
1/1/1990 (Month
Unknown)
Introduced into NIP:
Universal
11/1/2005 (Day
Unknown)
No Decision
SYRIAN ARAB REPUBLIC Introduced into NIP:
Universal
1/1/2001 (Month
Unknown)
No Decision
No Decision
TAJIKISTAN
Introduced into NIP:
Universal
8/1/2008 (Day
Unknown)
GAVI plan to apply
GAVI plan to apply
THAILAND
No Decision
No Decision
No Decision
MACEDONIA, THE
FORMER YUGOSLAV
REPUBLIC OF
Introduced into NIP:
Universal
No Decision
No Decision
TIMOR-LESTE
GAVI approved/
approved with
clarification
No Decision
Non-GAVI Planning
Introduction
TOGO
Introduced into NIP:
Universal
7/3/2008 (Exact)
GAVI conditional
approval to introduce
GAVI conditional
approval to introduce
TONGA
Introduced into NIP:
Universal
1/1/2005 (Month
Unknown)
No Decision
No Decision
TRINIDAD AND TOBAGO Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Risk
No Decision
TUNISIA
Introduced into NIP:
Universal
4/1/2011 (Day
Unknown)
No Decision
No Decision
TURKEY
Introduced into NIP:
Universal
1/1/2006 (Month
Unknown)
Introduced into NIP:
Universal
TURKMENISTAN
Introduced into NIP:
Universal
12/1/2010 (Month
Unknown)
No Decision
No Decision
TUVALU
Introduced into NIP:
Universal
7/1/2009 (Day
Unknown)
No Decision
No Decision
29
9/1/2008 (Day
Unknown)
Date of Introduction
Introduction Status
Non-GAVI Planning
Introduction
11/1/2008 (Day
Unknown)
No Decision
Date of Introduction
HIB
PNEUMO
ROTA
Country
Introduction Status
Date of Introduction
Introduction Status
UGANDA
Introduced into NIP:
Universal
1/1/2002 (Month
Unknown)
GAVI approved/
approved with
clarification
GAVI plan to apply
UKRAINE
Introduced into NIP:
Universal
9/1/2006 (Day
Unknown)
No Decision
No Decision
UNITED ARAB EMIRATES Introduced into NIP:
Universal
1/1/1999 (Month
Unknown)
Introduced into NIP:
Universal
6/1/2007 (Month
Unknown)
Non-GAVI Planning
Introduction
UNITED KINGDOM
Introduced into NIP:
Universal
1/1/1992 (Month
Unknown)
Introduced into NIP:
Universal
9/1/2006 (Day
Unknown)
No Decision
TANZANIA, UNITED
REPUBLIC OF
Introduced into NIP:
Universal
4/1/2009 (Exact)
GAVI approved/
approved with
clarification
UNITED STATES
Introduced into NIP:
Universal
1/1/1990 (Month
Unknown)
Introduced into NIP:
Universal
7/1/2000 (Day
Unknown)
Introduced into NIP:
Universal
URUGUAY
Introduced into NIP:
Universal
1/1/1994 (Month
Unknown)
Introduced into NIP:
Universal
3/1/2008 (Day
Unknown)
No Decision
UZBEKISTAN
Introduced into NIP:
Universal
3/1/2009 (Day
Unknown)
GAVI plan to apply
GAVI plan to apply
VANUATU
Introduced into NIP:
Universal
1/31/2011 (Day
Unknown)
No Decision
No Decision
VENEZUELA
Introduced into NIP:
Universal
1/1/2000 (Month
Unknown)
No Decision
Introduced into NIP:
Universal
VIET NAM
Introduced into NIP:
Universal
6/1/2010 (Exact)
GAVI plan to apply
No Decision
YEMEN
Introduced into NIP:
Universal
1/1/2005 (Month
Unknown)
Introduced into NIP:
Universal
ZAMBIA
Introduced into NIP:
Universal
2/1/2004 (Day
Unknown)
GAVI approved/
approved with
clarification
Introduced into NIP:
Regional
ZIMBABWE
Introduced into NIP:
Universal
1/1/2008 (Day
Unknown)
GAVI approved/
approved with
clarification
GAVI conditional
approval to introduce
30
Date of Introduction
Introduction Status
Date of Introduction
GAVI approved/
approved with
clarification
1/29/2011 (Exact)
1/1/2006 (Month
Unknown)
1/1/2006 (Month
Unknown)
GAVI approved/
approved with
clarification
1/23/2012 (Exact)
ACKNOWLEDGEMENTS AND NOTES
This report and the Vaccine Information Management System (VIMS) is supported by the GAVI Alliance, Johns Hopkins
Bloomberg School of Public Health and the International Vaccine Access Center (IVAC). This report has been generated
by the Vaccine Information Management System (VIMS) database developed and maintained at the Johns Hopkins
Bloomberg School of Public Health for use by the International Vaccine Access Center (IVAC) and its affiliated projects
and partners. VIMS provides a centralized, web-based warehouse for key information related to work in vaccine access
that all interested parties can use. Information was gathered from internationally recognized sources, such as UNICEF,
World Health Organization, vaccine manufacturers, ministries of health and news media.
Please note that all forecasted dates in this report rest on assumptions and actual dates may vary.
Vaccine introduction dates do not imply an obligation by GAVI to support coverage.
All information, methodologies and sources are available in the VIMS database.
This report can be found at: http://www.jhsph.edu/ivac/index.html. The full report with forecast data and a PowerPoint
presentation with graphics can be found in the VIMS database. To gain access to VIMS, please email [email protected].
31
SOURCES
GAVI Eligibility Status
DTP3 Coverage Rate
Surviving Infants
Projected Introduction Dates
Dates of Introduction
Current Vaccine Use Status
and Program Type
32
GAVI Alliance. GAVI Eligible Countries. 2011. Last accessed February 24, 2012 at
http://www.gavialliance.org/support/apply/countries-eligible-for-support/
World Health Organization. WHO Vaccine Preventable Diseases Monitoring System
(WHO/UNICEF Best Estimates). Aug 3, 2011. Last accessed Sept, 2011 at:
http://www.who.int/immunization_monitoring/data/data_subject/en/index.html
UNICEF. Immunization Summary (2012 Edition): A Statistical Reference Containing
Data through 2010. Last accessed February 24, 2012 at: http://www.childinfo.org/
immunization.html
This information comes from a variety of sources, primarily the most recent AVI
Strategic Demand Forecast and WHO regional projections. For more information,
please contact [email protected]
This information comes from a variety of sources, such as the GAVI Alliance,
WHO, UNICEF, ministries of health, the news media and IVAC partners/contacts.
For more information, please contact [email protected]
It is cross-referenced with WHO information (below).
Vaccine Introduction. World Health Organization. 2011. Updated 4 Jan, 2011.
Accessed at: http://www.who.int/entity/immunization_monitoring/data/year_
vaccine_introduction.xls
This information comes from a variety of sources, such as the GAVI Alliance,
WHO, UNICEF, ministries of health, the news media and IVAC partners/contacts.
For more information, please contact [email protected]
SELECTED KEY TERMS
Any definitions not provided below can be found in the Glossary located in the Help section in VIMS.
Children with Access: the number of children (based on surviving infants 2010) who live in a country that has introduced
the vaccine into the national immunization program. This does not include countries with widespread market use or
high-risk programs. For regional introductions, those regions that have introduced may be included and the regions
which have not introduced excluded.
Covered Children: the number of children (based on surviving infants of 2010) who are likely to receive the vaccination
based upon the coverage rates of countries who have introduced. The WHO/UNICEF best estimate DTP3 vaccination
coverage rate is used as a proxy for Hib, Pneumo and Rotavirus rates.
Introduced into national immunization program: the vaccine has been incorporated into the national government’s
immunization program, either for all children, an at-risk subset, or for a regional program and it may include programs
that are being phased in over time. This status can apply to any country, regardless of GAVI eligibility.
Regional: local government immunization programs, but the national government has not included the vaccine in its
immunization program.
Widespread coverage through private market: most (over half) of the target population is receiving the vaccine through
private market use.
Risk: program for this vaccine only covers children in specific high risk groups—this may include children with health
conditions, those of vulnerable socioeconomic statuses or ethnic groups, or those living in regions of high risk.
GAVI approved/clarification: the country’s application to GAVI for New and Underused Vaccines Support (NVS) financing
for this vaccine has been approved or approved with clarifications.
Approved: the application meets all the criteria and is approved for GAVI support.
Approved with clarification: the application lacks specific pieces of data, which must be provided generally within a
month. Data must be received before the application is considered officially approved for GAVI Support.
GAVI conditional approval to introduce: the application to GAVI for New and Underused Vaccines Support (NVS) for
this vaccine does not fulfill specific or significant application requirements. Missing requirements must be provided in
a subsequent round to complement the original application. If the conditions are not met within the given timeframe
after the first submission, re-submission of a new application is required.
GAVI Resubmission: the New and Underused Vaccines Support (NVS) application for this vaccine is incomplete and a
full application should be submitted in a future round.
GAVI application submitted under review: the country has submitted a New and Underused Vaccines Support (NVS)
application for this vaccine and is awaiting GAVI evaluation.
GAVI plan to apply: country has made a public statement (through government or other recommending body on vaccines)
that they plan to introduce the vaccine and apply for GAVI New and Underused Vaccines Support (NVS), but has not
yet submitted an application.
33
Non-GAVI Planning Introduction: a country that is not eligible for GAVI support has plans to introduce the vaccine
into its national immunization program, and has taken steps to initiate its program, such as contacting the vaccine
manufacturer. OR A country that is eligible for GAVI support and plans to introduce without it.
No Decision: the country has not indicated a firm decision to introduce the vaccine into its national immunization
program or to apply for GAVI New and Underused Vaccines Support (NVS) for the vaccine.
Unknown: sources differ or are unclear on whether this country has a national program or not.
34
APPENDIX
VIMS was conceived at the Johns Hopkins Bloomberg School of Public Health as a collaborative project between the
Hib Initiative, PneumoADIP and the GAVI Alliance. It provides a centralized, web-based warehouse for key information
related to the vaccine access. This includes data on the global uptake of Hib, Pneumococcal, Rotavirus and Hep B
vaccines; demographic indicators; and tools for strategic social mapping of key vaccine policy stakeholders and decision
makers. The data contained in VIMS can be accessed using the search functions within each tab, or downloaded via
the report generation functions. The data are continuously updated as information is received, so as to permit real time
reporting.
VIMS has been under development since 2008 and is now in full operational use by the International Vaccine Access
Center (IVAC). Bringing together inputs from a range of sources into one secure location, we believe this tool could be
of great use to the global vaccine community and are rolling it out to key partners.
Support and funding for VIMS is provided by the GAVI Alliance, Johns Hopkins Bloomberg School of Public Health,
and the International Vaccine Access Center (IVAC).
Use of VIMS:
Using VIMS, stakeholders can generate their own custom reports based on any combination of countries, demographic
data, and vaccine information, or print out specific country reports as needed.
Due to the sensitive nature of some of the information in VIMS, only authorized parties are given access to the system.
If you have further questions or would like to learn how to obtain a user ID for access to VIMS, please contact the
VIMS team at [email protected].
Any data on projected introduction dates should not be reproduced or disseminated without prior consent from VIMS
personnel. If data is used in a presentation, please cite VIMS accordingly:
Source: IVAC, Johns Hopkins Bloomberg School of Public Health. Vaccine Information Management System (VIMS)
Global Vaccine Introduction Report, March, 2012. www.jhsph.edu/ivac/vims.html. Accessed: Date of access.
Information on a particular country’s GAVI application status may be confidential. Please do not share this information
publicly without consent from VIMS personnel.
35